(Q36832873)

16 August 2017

1 reference

title

Immunopathogenesis of multiple sclerosis (English)

1 reference

16 August 2017

0 references

Smriti M Agrawal

1

1 reference

PubMed ID

17531839

16 August 2017

V Wee Yong

series ordinal

2

1 reference

16 August 2017

1 January 2007

1 reference

International Review of Neurobiology

16 August 2017

1 reference

16 August 2017

79

1 reference

16 August 2017

99-126

1 reference

Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephal

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Chemokines in experimental autoimmune encephalomyelitis and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Human regulatory T cells and their role in autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Immunology of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Human Monocyte-Derived Dendritic Cells Produce Bioactive Gelatinase B: Inhibition by IFN-β

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Glutamate receptors in neuroinflammatory demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

A functional dichotomy in CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Isolation of myelin basic protein-reactive T-cell lines from normal human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

1 reference

7 January 2021

In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Molecular mechanisms involved in T cell migration across the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

MMPs and ADAMTSs: functional studies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Migratory Activity and Functional Changes of Green Fluorescent Effector Cells before and during Experimental Autoimmune Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-gamma and -beta: implications to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patientswith relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Vulnerability of human neurons to T cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

1 reference

7 January 2021

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

The IL-23/IL-17 axis in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Binding of complement component Clq to myelin oligodendrocyte glycoprotein: A novel mechanism for regulating CNS inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Interferon-beta 1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Fatalities in natalizumab treatment--a 'no go' for leukocyte recirculation approaches?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

The immunoregulatory effects of Qa-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway,.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

A controlled trial of natalizumab for relapsing multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Lymphocyte traffic control by chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Complex gene–gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Gelatinase B: a tuner and amplifier of immune functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

UVR, vitamin D and three autoimmune diseases--multiple sclerosis, type 1 diabetes, rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Birth order, infection in early life, and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Pathology of the early lesion in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Immunoglobulins promote remyelination in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

1 reference

7 January 2021

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

From vanilla to 28 flavors: multiple varieties of T regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Immunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Immune surveillance in multiple sclerosis patients treated with natalizumab.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Regulatory T-cell physiology and application to treat autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Viruses and T cell turnover: evidence for bystander proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Subpopulations of human peripheral T gamma delta lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Changes of serum sICAM-1 and MMP-9 induced by rIFN -1b treatment in relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Activation of complement by myelin: identification of C1-binding proteins of human myelin from central nervous tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

TGFbeta1, a "Jack of all trades": the link with pro-inflammatory IL-17-producing T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

α4Integrins as Therapeutic Targets in Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Granzyme B mediates neurotoxicity through a G-protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Association between microchimerism and multiple sclerosis in Canadian twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Lipoic acid in multiple sclerosis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

The promise of minocycline in neurology.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979005-0

7 January 2021

10.1016/S0074-7742(07)79005-0

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17531839